Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Nautilus Biotechnology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 75 | 75 | 0 |
| Shares | 44.8M | 45.1M | +268.3K (+0.6%) |
| Value | $173.4M | $142.5M | −$31.0M (−17.9%) |
New holders (5)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CI Private Wealth, LLC | 45,350 | $143.3K | 0.00% |
| SG Americas Securities, LLC | 22,372 | $71.0K | 0.00% |
| Kestra Private Wealth Services, LLC | 11,897 | $37.6K | 0.00% |
| Federated Hermes, Inc. | 9,133 | $28.9K | 0.00% |
| Comerica Bank | 1,764 | $5.57K | 0.00% |
Sold out (5)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 42,445 | $164.3K |
| Lombard Odier Asset Management (USA) Corp | 25,000 | $96.8K |
| Mariner, LLC | 18,863 | $73.0K |
| Stifel Financial Corp | 13,063 | $50.6K |
| Buckingham Strategic Wealth, LLC | 10,711 | $41.5K |